Long Term Care Journal
Friday, February 16, 2018
FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing - FDA Press Releases
FDA approves drug to reduce the risk of stage III non-small cell lung cancer progressing
from Food and Drug Administration--Press Releases http://ift.tt/2EzkVXY
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment